Identification of bacterial strains for development of an oral probiotic aimed at increasing nitric oxide bioavailability
鉴定用于开发口服益生菌的菌株,旨在提高一氧化氮的生物利用度
基本信息
- 批准号:10666185
- 负责人:
- 金额:$ 19.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AdherenceAnemiaAnimal ModelAnionsAntibiotic ResistanceAtherosclerosisBackBacteriaBiological AssayBiological AvailabilityBloodCell LineCellsClinicalClinical ResearchClinical TrialsCongestive Heart FailureControl AnimalDataDevelopmentDiabetes MellitusDiseaseEpitheliumGenomicsGoalsHeart failureHemolytic AnemiaHomeostasisHumanHypertensionIndividualIntakeInterventionLeadLinkMalariaMethodsMicrobial BiofilmsMolecularNerve DegenerationNitratesNitric OxideNitritesNutrientObesityOralOral AdministrationOral CharactersOral cavityOral mucous membrane structureOrganOutcomePathogenicityPathologyPatientsPhasePhysiologicalPhysiologyPilot ProjectsPlasmaPlayProbioticsReportingRoleRouteSafetySalivaSalivary GlandsSignaling MoleculeSourceSystemTestingTherapeutic InterventionTissuesTongueTransfusionbasecandidate identificationcohortculture platesdesigndietary nitrateefficacy evaluationexercise capacityhigh throughput screeninghuman diseaseimprovedinnovationmicrobiomemicrobiome compositionmonolayermouse modelnoveloral bacteriaoral microbial communityoral microbiomescreeningtranslational applicationsvirulence gene
项目摘要
Nitric oxide (NO) plays critical roles in a myriad of cellular and molecular mechanisms regulating physiology
and function of various organs and systems. Depletion of NO and its reduced bioavailability contributes to the
pathology of several human diseases including anemia, malaria, heart failure, obesity, diabetes and
neurodegeneration. Recent reports suggest that oral microbiota regulate NO homeostasis through the action of
some bacteria that have the ability to perform reduction of the nutrient anion nitrate to nitrite and NO. Several
clinical trials have taken advantage of this nitrate-nitrite-NO cycle employing oral nitrate to deliver NO.
However, many individuals do not respond to oral nitrate, and we hypothesize that this is due to a deficiency in
nitrate to nitrite converting bacteria. Hence, developing microbiome modulators like probiotics to enhance
and/or perform increased nitrate reduction and NO formation can potentially serve as a solution to recover
diminished NO levels and bioavailability. The goal of this project is to test the role of oral bacteria in
determining the extent of conversion of oral nitrate to plasma nitrite while developing novel human-origin
probiotics of nitrate-nitrite-NO formation abilities and determine their adherence potential to colonize and form
biofilms in epithelia. In Aim 1 we will use novel, high throughput screening assays to identify candidate
bacterial strains with efficient nitrate to nitrite conversion abilities obtained from the oral cavity and characterize
these strains. In Aim 2 we will determine the oral cavity colonizing capabilities of the nitrate to nitrite converting
bacterial strains. In Aim 3, we will test the role of these bacterial strains’ in determining the extent of
conversion of oral nitrate to plasma nitrite in a murine model. Successful completion of these studies could
lead to probiotics against human diseases caused by NO homeostasis abrogation.
一氧化氮(NO)在调节生理的无数细胞和分子机制中起着关键作用
以及各种器官和系统的功能。NO的消耗及其降低的生物利用度有助于
包括贫血、疟疾、心力衰竭、肥胖症、糖尿病和
神经变性最近的报道表明,口腔微生物群通过以下作用调节NO稳态:
一些细菌具有将营养阴离子硝酸盐还原为亚硝酸盐和NO的能力。
临床试验利用了这种硝酸盐-亚硝酸盐-NO循环,使用口服硝酸盐来递送NO。
然而,许多人对口服硝酸盐没有反应,我们假设这是由于缺乏
将硝酸盐转化为亚硝酸盐的细菌。因此,开发微生物组调节剂,如益生菌,
和/或进行增加的硝酸盐还原和NO形成可以潜在地用作回收的解决方案
降低NO水平和生物利用度。该项目的目标是测试口腔细菌在
确定口服硝酸盐转化为血浆亚硝酸盐的程度,同时开发新的人源性
益生菌的硝酸盐-亚硝酸盐-NO形成能力,并确定其粘附的潜力,
上皮中的生物膜。在目标1中,我们将使用新的高通量筛选方法来鉴定候选药物。
从口腔中获得的具有有效的硝酸盐至亚硝酸盐转化能力的细菌菌株,
这些菌株。在目标2中,我们将确定硝酸盐转化为亚硝酸盐的口腔定殖能力
细菌菌株在目标3中,我们将测试这些细菌菌株的作用,以确定程度,
在小鼠模型中口服硝酸盐转化为血浆亚硝酸盐。成功完成这些研究可以
导致益生菌对抗由NO稳态破坏引起的人类疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL B KIM-SHAPIRO其他文献
DANIEL B KIM-SHAPIRO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL B KIM-SHAPIRO', 18)}}的其他基金
Nitric Oxide Donor Compounds for the Treatment of Hemolytic Conditions
用于治疗溶血病症的一氧化氮供体化合物
- 批准号:
7387531 - 财政年份:2008
- 资助金额:
$ 19.78万 - 项目类别:
Nitric Oxide Donor Compounds for the Treatment of Hemolytic Conditions
用于治疗溶血病症的一氧化氮供体化合物
- 批准号:
7554123 - 财政年份:2008
- 资助金额:
$ 19.78万 - 项目类别:
Nitrite and Nitric Oxide in Sickle Cell Blood
镰状细胞血中的亚硝酸盐和一氧化氮
- 批准号:
7166100 - 财政年份:2004
- 资助金额:
$ 19.78万 - 项目类别:
Nitrite and Nitric Oxide in Sickle Cell Blood
镰状细胞血中的亚硝酸盐和一氧化氮
- 批准号:
6848917 - 财政年份:2004
- 资助金额:
$ 19.78万 - 项目类别:
Nitrite and Nitric Oxide in Sickle Cell Blood
镰状细胞血中的亚硝酸盐和一氧化氮
- 批准号:
7328594 - 财政年份:2004
- 资助金额:
$ 19.78万 - 项目类别:
Nitrite and Nitric Oxide in Sickle Cell Blood
镰状细胞血中的亚硝酸盐和一氧化氮
- 批准号:
6999383 - 财政年份:2004
- 资助金额:
$ 19.78万 - 项目类别:
Nitrite and Nitric Oxide in Sickle Cell Blood
镰状细胞血中的亚硝酸盐和一氧化氮
- 批准号:
7536043 - 财政年份:2004
- 资助金额:
$ 19.78万 - 项目类别:
STOPPED-FLOW OPTICAL ROTATARY DISPERSION SPECTROMETER
停流光学旋转色散光谱仪
- 批准号:
6016628 - 财政年份:1999
- 资助金额:
$ 19.78万 - 项目类别:
MECHANISM AND KINETICS OF SICKLE CELL HEMOGLOBIN
镰状细胞血红蛋白的机制和动力学
- 批准号:
2456404 - 财政年份:1998
- 资助金额:
$ 19.78万 - 项目类别:
相似国自然基金
基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
- 批准号:82302715
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
- 批准号:
- 批准年份:2021
- 资助金额:10.0 万元
- 项目类别:省市级项目
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
- 批准号:31200592
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastoma
范可尼贫血通路与 ATM 之间的串扰研究,用于化疗耐药 ALT 阳性高危神经母细胞瘤的新治疗策略
- 批准号:
24K10442 - 财政年份:2024
- 资助金额:
$ 19.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Immune escape mechanisms in BCOR/BCORL1 mutant hematopoietic stem cells from patients with aplastic anemia
再生障碍性贫血患者 BCOR/BCORL1 突变型造血干细胞的免疫逃逸机制
- 批准号:
23K15297 - 财政年份:2023
- 资助金额:
$ 19.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Fanconi anemia経路に着目したiPS細胞における高レベル複製ストレスの原因解明
阐明 iPS 细胞中高水平复制应激的原因,重点关注范可尼贫血途径
- 批准号:
23K14452 - 财政年份:2023
- 资助金额:
$ 19.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Analysis of the mechanism of hemolytic anemia in canine babesiosis and development of novel therapeutic measures
犬巴贝斯虫病溶血性贫血机制分析及新治疗措施开发
- 批准号:
23KJ0074 - 财政年份:2023
- 资助金额:
$ 19.78万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Mobile phone-based screening for anemia in young children in western Kenya
基于手机的肯尼亚西部幼儿贫血筛查
- 批准号:
10752968 - 财政年份:2023
- 资助金额:
$ 19.78万 - 项目类别:
Brain blood flow, oxygenation, and cognition in adult onset iron deficiency anemia
成人缺铁性贫血的脑血流量、氧合和认知
- 批准号:
10735765 - 财政年份:2023
- 资助金额:
$ 19.78万 - 项目类别:
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
范可尼贫血血液疾病和骨髓衰竭中的染色质状态改变
- 批准号:
10735366 - 财政年份:2023
- 资助金额:
$ 19.78万 - 项目类别:
Accuracy and Feasibility of Non-Invasive Anemia Screening Assistant (ASIST) Device in Resource-Limited Settings
资源有限环境中非侵入性贫血筛查辅助 (ASIST) 设备的准确性和可行性
- 批准号:
10575222 - 财政年份:2023
- 资助金额:
$ 19.78万 - 项目类别:
Liver-Gut Axis in Neonatal Anemia and Its Role in RBC Transfusion Associated Gut Injury
新生儿贫血中的肝肠轴及其在红细胞输注相关肠道损伤中的作用
- 批准号:
10583807 - 财政年份:2023
- 资助金额:
$ 19.78万 - 项目类别:
A Sample-to-Answer Point-of-Care Diagnostic for Recently Transfused Sickle Cell Anemia Patients in Low Resource Settings
针对资源匮乏地区最近输血的镰状细胞性贫血患者的从样本到答案的护理点诊断
- 批准号:
10564553 - 财政年份:2023
- 资助金额:
$ 19.78万 - 项目类别: